Lombard Medical (EVARF) Stock Price, News & Analysis

Company Overview

Lombard Medical is a Salt Lake City–based medical device company focused on the development, manufacture and commercialization of vascular closure systems designed to achieve hemostasis following diagnostic and interventional catheter-based procedures. Its flagship product, ExoSeal™, is a fully absorbable, sutureless closure device engineered to seal femoral access sites quickly, reducing patient recovery times and minimizing complication risks. In addition to ExoSeal™, the company offers the VASCADE™ vascular closure patch and a specialized delivery system for small- and large-bore access, serving demanding clinical environments such as interventional cardiology, radiology and peripheral vascular interventions.

Founded in the early 2000s, Lombard Medical has secured regulatory clearances in the United States, Europe and select Asia-Pacific markets. The company’s products carry CE marking and have been introduced in major hospital networks across North America, Latin America and Europe, where they are utilized by physicians seeking reliable, reproducible closure solutions. Over the years, Lombard Medical has expanded its global distribution channels, forged partnerships with leading medical device distributors and invested in ongoing clinical research to validate performance and broaden its application to a wider range of interventional procedures.

Lombard Medical’s management team is led by President and Chief Executive Officer Todd Kahle, who brings more than 25 years of experience in medical technology development and commercialization. Supporting him is a leadership group with deep expertise in regulatory affairs, clinical affairs and global marketing. The board of directors includes seasoned professionals from the healthcare industry and financial sector, guiding strategic growth initiatives and exploring next-generation hemostasis solutions. As it advances its pipeline and extends its international footprint, Lombard Medical remains committed to improving patient outcomes and simplifying vascular closure for clinicians worldwide.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EVARF Stock Analysis - Frequently Asked Questions

How were Lombard Medical's earnings last quarter?

Lombard Medical, Inc. (OTCMKTS:EVARF) posted its quarterly earnings results on Thursday, October, 27th. The medical equipment provider reported ($0.37) EPS for the quarter, missing the consensus estimate of ($0.27) by $0.11. The medical equipment provider had revenue of $3.04 million for the quarter, compared to analyst estimates of $3.16 million.

How do I buy shares of Lombard Medical?

Shares of EVARF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 10/27/2016
• Today: 7/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:EVARF
• Previous Symbol: NASDAQ:EVAR
• CIK: N/A
• Web: www.lombardmedical.com
• Phone: 44121235750800
• Fax: 44-0-12-3575-0879
• Employees: 111
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A